Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy, Biol. Psychiatry, vol.63, pp.642-649, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00343691
Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation, Int. J. Neuropsychopharmacol, vol.6, pp.41-49, 2003. ,
High-speed imaging reveals neurophysiological links to behavior in an animal model of depression, Science, vol.317, pp.819-823, 2007. ,
Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study, Int. Clin. Psychopharmacol, vol.21, pp.117-124, 2006. ,
Reversal of depressed behaviors in mice by p11, 2010. ,
, the nucleus accumbens, vol.2, pp.54-76
Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression, J. Affect. Disord, vol.119, pp.132-141, 2009. ,
Microstructural white matter abnormalities and remission of geriatric depression, Am. J. Psychiatry, vol.165, pp.238-244, 2008. ,
Does thyroid supplementation accelerate tricyclic antidepressant response. A review and meta-analysis of the literature, Am. J. Psychiatry, vol.158, pp.1617-1622, 2001. ,
Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study, Neuropsychopharmacology, vol.30, pp.1334-1344, 2005. ,
The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys, Int. J. Methods Psychiatr. Res, vol.12, pp.3-21, 2003. ,
Triiodothyronine augmentation in treatment of refractory depression, Arch. Gen. Psychiatry, vol.53, pp.842-848, 1996. ,
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response, Mol. Psychiatry, vol.17, pp.926-939, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00661249
The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men, Neurosci. Lett, vol.363, pp.38-42, 2004. ,
Novel Insights into depression and antidepressants: a synergy between synaptogenesis and neurogenesis, Neurogenesis and Neural Plasticity, vol.15, 2013. ,
, , pp.243-291
Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder, Eur. Psychiatry, vol.23, pp.350-355, 2008. ,
BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity, Neuropsychopharmacology, vol.37, pp.1297-1304, 2012. ,
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care, World J. Biol. Psychiatry, vol.8, pp.67-104, 2007. ,
Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy, J. Clin. Endocrinol. Metab, vol.94, pp.2922-2929, 2009. ,
Association of the COMT val158met variant with antidepressant treatment response in major depression, Neuropsychopharmacology, vol.33, pp.924-932, 2008. ,
The design of new antidepressants: can formal models help. A first attempt using a model of the hippocampal control over the HPA axis based on a review from the literature, Behav. Pharmacol, vol.21, pp.677-689, 2010. ,
Blood-brain barrier: recent developments and clinical correlations, Neurology, vol.78, pp.1268-1276, 2012. ,
The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting, Psychopharmacology, vol.203, pp.155-160, 2009. ,
What is the meaning of treatment resistant/refractory major depression (TRD). A systematic review of current randomized trials, Eur. Neuropsychopharmacol, vol.17, pp.696-707, 2007. ,
Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression, Int. J. Neuropsychopharmacol, vol.12, pp.1033-1044, 2009. ,
The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling, Mol. Psychiatry, vol.14, pp.764-773, 2009. ,
Longterm effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy, Neuropsychopharmacology, vol.37, 1975. ,
HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients, Psychoneuroendocrinology, vol.34, pp.99-109, 2009. ,
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment, Nat. Genet, vol.36, pp.1319-1325, 2004. ,
Do stressful life events predict medical treatment outcome in first episode of depression, Soc. Psychiatry Psychiatr. Epidemiol, vol.44, pp.752-760, 2009. ,
Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI, Invest. Radiol, vol.36, pp.470-479, 2001. ,
Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression, Biol. Psychiatry, vol.72, pp.562-571, 2012. ,
Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression, Neuropsychopharmacology, vol.38, pp.1068-1077, 2013. ,
Antidepressants increase neural progenitor cells in the human hippocampus, Neuropsychopharmacology, vol.34, pp.2376-2389, 2009. ,
Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated byalpha1-adrenergic receptors in medial prefrontal cortex, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.34, pp.913-923, 2010. ,
Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation, Psychopharmacology (Berl.), vol.128, pp.421-425, 1996. ,
Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.29, pp.1094-1099, 2005. ,
Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects, Mol. Psychiatry, vol.17, pp.612-623, 2012. ,
Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatmentresistant depression: a pilot study, Neuropsychopharmacology, vol.37, pp.1764-1772, 2012. ,
Triiodothyronine potentiation of antidepressant-induced reversal of learned helplessness in rats, Psychiatry Res, vol.21, pp.267-275, 1987. ,
Some aspects of genetic polymorphism in the biotransformation of antidepressants, Therapie, vol.59, pp.5-12, 2004. ,
Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression, Psychoneuroendocrinology, vol.31, pp.1154-1163, 2006. ,
Selective p38? MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction, Neuron, vol.71, pp.498-511, 2011. ,
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre-and post-treatment findings, Biol. Psychiatry, vol.63, pp.1171-1177, 2008. ,
Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men, Neuropsychopharmacology, vol.29, pp.1752-1761, 2004. ,
Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant, Biol. Psychiatry, vol.48, pp.416-425, 2001. ,
Adult-born hippocampal neurons promote cognitive flexibility in mice, Hippocampus, vol.22, pp.1795-1808, 2012. ,
Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy, Psychiatry Res, vol.157, pp.123-129, 2008. ,
A placebo-controlled study of sertraline's effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adults, Psychopharmacology (Berl.), vol.218, pp.371-379, 2011. ,
Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets, Neuropsychopharmacology, vol.38, pp.377-385, 2013. ,
Psychosocial and psychiatric risk factors for suicide. Case-control psychological autopsy study, Br. J. Psychiatry, vol.177, pp.360-365, 2000. ,
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior, Science, vol.314, pp.140-143, 2006. ,
Preliminary evidence for white matter tract abnormalities in young adults exposed to parental verbal abuse, Biol. Psychiatry, vol.65, pp.227-234, 2009. ,
A functional role for adult hippocampal neurogenesis in spatial pattern separation, Science, vol.325, pp.210-213, 2009. ,
Interactions between antidepressants and antihypertensive and glucose lowering drugs among patients in the HIPERDIA Program, Cad. Saude Publica, vol.25, pp.2229-2236, 2009. ,
Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors, Mol. Psychiatry, vol.16, pp.533-547, 2011. ,
cAMP response element-binding protein is essential for the upregulation of brainderived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs, J. Neurosci, vol.22, pp.3262-3268, 2002. ,
Midline and right frontal brain function as a physiologic biomarker of remission in major depression, Psychiatry Res, vol.174, pp.152-157, 2009. ,
Early changes in prefrontal activity characterize clinical responders to antidepressants, Neuropsychopharmacology, vol.27, pp.294-298, 2002. ,
Ageing abolishes the effects of fluoxetine on neurogenesis, Mol. Psychiatry, vol.14, pp.856-864, 2009. ,
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents, Cochrane Database Syst. Rev, vol.11, p.8324, 2012. ,
Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs, J. Pharmacol. Exp. Ther, vol.298, pp.651-657, 2001. ,
Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine2C receptors, J. Pharmacol. Exp. Ther, vol.295, pp.1120-1126, 2000. ,
5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test, Eur. J. Pharmacol, vol.409, pp.295-299, 2000. ,
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotoninreuptake inhibitors, Proc. Natl. Acad. Sci. U.S.A, vol.101, pp.8186-8191, 2004. ,
Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis, Biol. Psychiatry, vol.52, pp.1457-1466, 2002. ,
Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3, 4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis, J. Pharmacol. Exp. Ther, vol.321, pp.237-248, 2007. ,
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression, Neuron, vol.62, pp.479-493, 2009. ,
The neural substrates of affective processing in depressed patients treated with venlafaxine, Am. J. Psychiatry, vol.160, pp.64-75, 2003. ,
The human ATP-binding cassette (ABC) transporter superfamily, Genome Res, vol.11, pp.1156-1166, 2001. ,
ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder, Pharmacogenomics J, vol.13, pp.349-353, 2012. ,
Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action, Biol. Psychiatry, vol.46, pp.212-220, 1999. ,
Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine, J. Affect. Disord, vol.65, pp.243-252, 2001. ,
Adult-born hippocampal dentate granule cells undergoing maturation modulate learning and memory in the brain, J. Neurosci, vol.29, pp.13532-13542, 2009. ,
5-HT(2B) receptors are required for serotonin-selective antidepressant actions, Mol. Psychiatry, vol.17, pp.154-163, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00652573
Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression, Eur. Neuropsychopharmacol, vol.18, pp.751-759, 2008. ,
Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.32, pp.224-228, 2008. ,
A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment, Biol. Psychiatry, vol.61, pp.661-670, 2007. ,
A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists, Philos. Transl. R. Soc. Lond. B Biol. Sci, vol.367, pp.2475-2484, 2012. ,
Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder, J. Affect. Disord, vol.145, pp.115-119, 2013. ,
Executive dysfunction predicts nonresponse to fluoxetine in major depression, J. Affect. Disord, vol.60, pp.13-23, 2000. ,
Spatial relational memory requires hippocampal adult neurogenesis, PLoS ONE, vol.3, p.1959, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-02325925
Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum, Neuropharmacology, vol.61, pp.442-450, 2011. ,
Depression and hippocampal neurogenesis: a road to remission, Science, vol.338, pp.72-75, 2012. ,
The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: possible role in antidepressant-augmenting properties, Int. J. Neuropsychopharmacol, vol.13, pp.553-561, 2010. ,
Vulnerability to depression: what is the role of stress genes in gene x environment interaction, Psychol. Med, vol.39, pp.1407-1411, 2009. ,
Bidirectional regulation of emotional memory by 5-HT(1B) receptors involves hippocampal p11, Mol. Psychiatry, vol.18, pp.1096-1105, 2013. ,
Treating depression and depressionlike behavior with physical activity: an immune perspective, Front. Psychiatry, vol.4, p.3, 2013. ,
Diagnosis and definition of treatment-resistant depression, Biol. Psychiatry, vol.53, pp.649-659, 2003. ,
Prediction of longer-term outcome of treatment-resistant depression in tertiary care, Br. J. Psychiatry, vol.201, pp.369-375, 2012. ,
The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms, J. Clin. Psychiatry, vol.70, pp.952-957, 2009. ,
The application of triiodothyronine in the treatment of mental disorders, J. Nerv. Ment. Dis, vol.127, pp.540-545, 1958. ,
Treatment of psychiatric disorders with triiodothyronine, Am. J. Psychiatry, vol.114, pp.841-842, 1958. ,
Antidepressant drug effects and depression severity: a patient-level meta-analysis, JAMA, vol.303, pp.47-53, 2010. ,
Neural responses to sad facial expressions in major depression following cognitive behavioral therapy, Biol. Psychiatry, vol.64, pp.505-512, 2008. ,
Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder, JAMA Psychiatry, vol.70, pp.280-290, 2013. ,
Deletion of running-induced hippocampal neurogenesis by irradiation prevents development of an anxious phenotype in mice, PLoS ONE, vol.5, p.12769, 2010. ,
Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder, Am. J. Psychiatry, vol.167, pp.565-573, 2010. ,
Antidepressants for bipolar depression: a systematic review of randomized, controlled trials, Am. J. Psychiatry, vol.161, pp.1537-1547, 2004. ,
Androgenic influence on serotonergic activation of the HPA stress axis, Endocrinology, vol.152, 2001. ,
Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting, Eur. J. Clin. Pharmacol, vol.60, pp.329-336, 2004. ,
P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline, J. Psychopharmacol, vol.18, pp.66-74, 2004. ,
Cytochrome P450 and chemical toxicology, Chem. Res. Toxicol, vol.21, pp.70-83, 2008. ,
Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice, Neuropsychopharmacology, vol.31, pp.2162-2172, 2006. ,
Characterization of 5-HT(1A/1B)-/-mice: an animal model sensitive to anxiolytic treatments, Neuropharmacology, vol.61, pp.478-488, 2011. ,
Altered white matter integrity of forebrain in treatmentresistant depression: a diffusion tensor imaging study with tract-based spatial statistics, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.38, pp.201-206, 2012. ,
Relationships among neurocognition, symptoms, and functioning in treatment-resistant depression, Arch. Clin. Neuropsychol, vol.28, pp.272-281, 2013. ,
The link between thyroid function and depression, J. Thyroid Res, p.8, 2012. ,
Resistance to depression through interference of opioid and nitrergic systems in bile-duct ligated mice, Eur. J. Pharmacol, vol.708, pp.38-43, 2013. ,
Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats, Biol. Psychiatry, vol.67, pp.117-124, 2010. ,
A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, vol.23, pp.56-62, 1960. ,
Depression, antidepressants, and neurogenesis: a critical reappraisal, Neuropsychopharmacology, vol.36, pp.2589-2602, 2011. ,
Allelic variation of human serotonin transporter gene expression, J. Neurochem, vol.66, pp.2621-2624, 1996. ,
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients-findings from the Munich Antidepressant Response Signature (MARS) project, J. Psychiatr. Res, vol.43, pp.215-229, 2009. ,
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update, Pharmacopsychiatry, vol.44, pp.195-235, 2011. ,
Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor, Neuropsychopharmacology, vol.33, pp.406-417, 2008. ,
Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter, Neuropsychopharmacology, vol.27, pp.374-377, 2002. ,
The corticosteroid receptor hypothesis of depression, Neuropsychopharmacology, vol.23, pp.477-501, 2000. ,
The influence of stressful life events on development of depression and treatment response in the population of patients in higher age, Ceska Slov. Psychiatr, vol.106, pp.311-317, 2011. ,
Grapefruit juice-fluvoxamine interaction -is it risky or not, J. Clin. Psychopharmacol, vol.23, pp.422-424, 2003. ,
Pharmacogenomics of antidepressant drugs, Pharmacol. Ther, vol.124, pp.57-73, 2009. ,
Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment, Neuropsychopharmacology, vol.35, pp.727-740, 2010. ,
Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients, Eur. Neuropsychopharm, vol.18, pp.214-215, 2008. ,
Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress, Behav. Brain Res, vol.202, pp.245-251, 2009. ,
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.35, pp.1155-1159, 2011. ,
Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis, J. Clin. Psychiatry, vol.73, pp.1300-1306, 2012. ,
Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression-a potential biomarker, Biol. Psychiatry, vol.62, pp.47-54, 2007. ,
Influence of ABCB1 (P-glycoprotein) haplotypes on nortriptyline pharmacokinetics and nortriptyline-induced postural hypotension in healthy volunteers, Br. J. Clin. Pharmacol, vol.73, pp.619-628, 2012. ,
Economic factors in of patients' nonadherence to antidepressant treatment, Soc. Psychiatry Psychiatr. Epidemiol, vol.47, 1985. ,
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic-and antidepressant-like effects, J. Clin. Investig, vol.115, pp.3104-3116, 2005. ,
Factors affecting therapeutic compliance: a review from the patient's perspective, Ther. Clin. Risk Manag, vol.4, pp.269-286, 2008. ,
Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatment, Eur. Neuropsychopharmacol, vol.23, pp.1636-1644, 2013. ,
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.32, pp.398-404, 2008. ,
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder, Mol. Psychiatry, vol.15, pp.473-500, 2010. ,
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression, Neuropsychobiology, vol.56, pp.167-171, 2007. ,
Gene-environment interaction in major depression and antidepressant treatment response, Curr. Psychiatry Rep, vol.14, pp.129-137, 2012. ,
Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP, J. Affect. Disord, vol.127, pp.337-342, 2010. ,
Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project, Pharmacogenomics J, vol.11, pp.138-145, 2011. ,
Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO world mental health survey initiative, Depress. Anxiety, vol.27, pp.351-364, 2010. ,
The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI), Int. J. Methods Psychiatr. Res, vol.13, pp.93-121, 2004. ,
Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications, J. Clin. Psychiatry, vol.72, pp.464-472, 2011. ,
Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.32, pp.375-379, 2008. ,
Genetic variants in FKBP5 affecting response to antidepressant drug treatment, Pharmacogenomics, vol.9, pp.841-846, 2008. ,
Initial severity and antidepressant benefits: a metaanalysis of data submitted to the Food and Drug Administration, PLoS Med, vol.5, 2008. ,
Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression, Psychopharmacol. Bull, vol.30, pp.489-494, 1994. ,
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels, Eur. Neuropsychopharmacol, vol.23, pp.653-662, 2013. ,
, , 1996.
, Quantitative EEG in the prediction of antidepressant response to imipramine, J. Affect. Disord, vol.39, pp.175-184
Requirement of AQP4 for antidepressive efficiency of fluoxetine: implication in adult hippocampal neurogenesis, Neuropsychopharmacology, vol.34, pp.1263-1276, 2009. ,
The molecular neurobiology of depression, Nature, vol.455, pp.894-902, 2008. ,
Hippocampal volume and 2-year outcome in depression, Br. J. Psychiatry, vol.192, pp.472-473, 2008. ,
Major depressive disorder: new clinical, neurobiological, and treatment perspectives, Lancet, vol.379, issue.11, pp.60602-60610, 2012. ,
ABCB1 (P-glycoprotein/MDR1) gene G2677T/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline, Clin. Chem, vol.52, pp.893-895, 2006. ,
Onset, time course and trajectories of improvement with antidepressants, Eur. Neuropsychopharmacol, vol.22, pp.492-498, 2012. ,
Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder, Biol. Psychiatry, vol.62, pp.1272-1280, 2007. ,
Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas, Neuroimage, vol.63, pp.874-881, 2012. ,
Therapy-resistant depressions -a clinical classification, Pharmakopsychiatr. Neuropsychopharmakol, vol.7, pp.156-163, 1974. ,
Glucocorticoids orchestrate divergent effects on mood through adult neurogenesis, J. Neuroscience, vol.33, pp.2961-2972, 2013. ,
The FKBP5-gene in depression and treatment response-an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort, Biol. Psychiatry, vol.63, pp.1103-1110, 2008. ,
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder, Psychiatry Res, vol.169, pp.132-138, 2009. ,
Biomarkers to predict antidepressant response, Curr. Psychiatry Rep, vol.12, pp.553-562, 2010. ,
mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists, Science, vol.329, pp.959-964, 2010. ,
Basic mechanisms of augmentation of antidepressant effects with thyroid hormone, Curr. Drug Targets, vol.7, pp.203-210, 2006. ,
Effect of triiodothyronine on antidepressant screening tests in mice and on presynaptic 5-HT1A receptors: mediation by thyroid hormone ? receptors, J. Pharmacol. Exp. Ther, vol.337, pp.494-502, 2011. ,
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment, Pharmacogenet. Genomics, vol.21, pp.163-170, 2011. ,
Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1, Neuropsychopharmacology, vol.32, pp.1531-1539, 2007. ,
Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders, Neurosci. Lett, vol.414, pp.155-158, 2007. ,
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression, J. Neurosurg, vol.116, pp.315-322, 2012. ,
Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression, Biol. Psychiatry, vol.64, pp.461-467, 2008. ,
, , 2007.
)) receptor agonists are putative antidepressants with a rapid onset of action, Neuron, vol.55, issue.4, pp.712-725 ,
Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder, Biol. Psychiatry, vol.64, pp.880-883, 2008. ,
Increased neurogenesis in a model of electroconvulsive therapy, Biol. Psychiatry, vol.47, pp.228-234, 2000. ,
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus, J. Neurosci, vol.20, pp.9104-9110, 2000. ,
Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression, Biol. Psychiatry, vol.65, pp.267-275, 2009. ,
Interaction between SERTPR and stressful life events on response to antidepressant treatment, Eur. Neuropsychopharmacol, vol.19, pp.64-67, 2009. ,
The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks, J. Am. Acad. Child Adolesc. Psychiatry, vol.45, pp.1393-1403, 2006. ,
Thyroid function and reversal by antidepressant drugs of depressive-like behavior (escape deficits) in rats, Neuropsychobiology, vol.18, pp.21-26, 1987. ,
Sustained remission from depressive-like behavior depends on hippocampal neurogenesis, Transl. Psychiatry, vol.3, p.210, 2013. ,
Cingulate function in depression: a potential predictor of treatment response, Neuroreport, vol.8, pp.1057-1061, 1997. ,
Deep brain stimulation for treatment-resistant depression, Neuron, vol.45, pp.651-660, 2005. ,
GRIK4 and the kainate receptor, Am. J. Psychiatry, vol.164, p.1148, 2007. ,
Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice, J. Pharmacol. Exp. Ther, vol.298, pp.1101-1107, 2001. ,
Toward a neuroimaging treatment selection biomarker for major depressive disorder, JAMA Psychiatry, vol.12, pp.1-9, 2013. ,
Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study, Neuropsychobiology, vol.62, pp.193-197, 2010. ,
MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.32, pp.1439-1444, 2008. ,
Effect of cerebrovascular risk factors on depression treatment outcome in later life, Am. J. Geriatr. Psychiatry, vol.10, pp.592-598, 2002. ,
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes, J. Psychopharmacol, vol.26, pp.1391-1398, 2012. ,
Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment, Psychopharmacology (Berl.), vol.227, pp.509-519, 2013. ,
Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment, Mol. Psychiatry, vol.16, pp.1088-1095, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00578453
Social factors and the psychobiology of depression: relations between life stress and rapid eye movement sleep latency, J. Abnorm. Psychol, vol.101, pp.528-537, 1992. ,
Essential role of brain-derived neurotrophic factor in adult hippocampal function, Proc. Natl. Acad. Sci. U.S.A, vol.101, pp.10827-10832, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-00142913
A new depression scale designed to be sensitive to change, Br. J. Psychiatry, vol.134, pp.382-389, 1979. ,
Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise, Proc. Natl. Acad. Sci. U.S.A, vol.109, pp.13094-13099, 2012. ,
CYP2C19 variation and citalopram response, Pharmacogenet. Genomics, vol.21, pp.1-9, 2011. ,
Prediction of treatment response in major depression: integration of concepts, J. Affect. Disord, vol.98, pp.215-225, 2007. ,
A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder, J. Psychiatry Neurosci, vol.34, pp.41-54, 2009. ,
The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants, Mol. Psychiatry, vol.5, pp.32-38, 2000. ,
Young dentate granule cells mediate pattern separation, whereas old granule cells facilitate pattern completion, Cell, vol.149, pp.188-201, 2012. ,
Pharmacogenetics of antidepressant drugs: current clinical practice and future directions, Pharmacogenomics, vol.13, pp.441-464, 2012. ,
Symptoms of late-life depression: frequency and change during treatment, Am. J. Geriatr. Psychiatry, vol.13, pp.520-526, 2005. ,
Depression: Management of Depression in Primary and Secondary Care. London: Clinical guidelines, CG23, National Institute for Clinical Excellence, 2004. ,
Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression, J. Clin. Psychiatry, vol.62, pp.5-9, 2001. ,
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report, Am. J. Psychiatry, vol.163, pp.1519-1530, 2006. ,
Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression, Neuropsychopharmacology, vol.37, pp.2210-2221, 2012. ,
Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings, Br. J. Pharmacol, vol.165, pp.289-312, 2012. ,
SMARCA3, a chromatin remodeling factor, is required for p11-dependent antidepressant action, Cell, vol.152, pp.831-843, 2013. ,
Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test, Psychopharmacology (Berl.), vol.192, pp.357-371, 2007. ,
Heat-shock protein-70 genes and response to antidepressants in major depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.31, pp.1006-1011, 2007. ,
Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy, Pharmacogenet. Genomics, vol.17, pp.69-75, 2007. ,
Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies, Int. Clin. Psychopharmacol, vol.24, pp.19-25, 2009. ,
Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment, J. Affect. Disord, vol.104, pp.83-90, 2007. ,
Depression, stress and the adrenal axis, J. Neuroendocrinol, vol.15, pp.811-812, 2003. ,
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment, Biol. Psychiatry, vol.49, pp.391-404, 2001. ,
A single DEX/CRH test in male drug-free depressed patients is associated with the clinical response to treatment with fluoxetine, J. Psychiatr. Res, vol.44, pp.1154-1157, 2010. ,
Neuropsychiatric disorders in cushing's syndrome, Neuroendocrinology, vol.92, pp.65-70, 2010. ,
Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates, J. Neurosci, vol.27, pp.4894-4901, 2007. ,
Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates, PLoS ONE, vol.6, p.17600, 2011. ,
Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample, PLoS ONE, vol.3, p.1872, 2008. ,
The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building, Neuropharmacology, vol.62, pp.21-34, 2012. ,
Increased depressive behaviour in mice harboring the mutant thyroid hormone receptor alpha 1, Behav. Brain Res, vol.214, pp.187-192, 2010. ,
Frontocingulate dysfunction in depression: toward biomarkers of treatment response, Neuropsychopharmacology, vol.36, pp.183-206, 2011. ,
Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis, Am. J. Psychiatry, vol.158, pp.405-415, 2001. ,
Genetics and antidepressants: where we are, Clin Neuropsychiatry, vol.8, pp.99-150, 2011. ,
Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials, J. Neurol. Neurosurg. Psychiatry, vol.82, pp.914-923, 2011. ,
The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles, Ann. Clin. Psychiatry, vol.24, pp.82-90, 2012. ,
Neural stem cell proliferation is decreased in schizophrenia, but not in depression, Mol. Psychiatry, vol.11, pp.514-522, 2006. ,
Adult hippocampal neurogenesis is involved in anxiety-related behaviors, Mol. Psychiatry, vol.14, pp.959-967, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02325920
Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation, Exp. Neurol, vol.214, pp.259-265, 2008. ,
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants, Neuron, vol.65, pp.40-52, 2010. ,
Pharmacokinetic interactions of antidepressants, J. Clin. Psychiatry, vol.59, pp.22-26, 1998. ,
Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies, Patient Prefer. Adherence, vol.7, pp.151-169, 2013. ,
A common P-glycoprotein polymorphism is associated with nortriptylineinduced postural hypotension in patients treated for major depression, Pharmacogenomics J, vol.2, pp.191-196, 2002. ,
Cognitive mechanisms of treatment in depression, Neuropsychopharmacology, vol.37, pp.117-136, 2012. ,
Staging methods for treatment resistant depression. A systematic review, J. Affect. Disord, vol.137, pp.35-45, 2012. ,
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, Am. J. Psychiatry, vol.163, pp.1905-1917, 2006. ,
Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects, J. Neurosci, vol.23, pp.349-357, 2003. ,
The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression, J. Clin. Psychopharmacol, vol.10, pp.96-104, 1990. ,
Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation, Nature, vol.472, pp.466-470, 2011. ,
Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine, Biol. Psychiatry, vol.65, pp.289-295, 2009. ,
Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms, Biol. Psychiatry, vol.61, pp.822-825, 2007. ,
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders, Nat. Rev. Drug. Discov, vol.7, pp.426-437, 2008. ,
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, Science, vol.301, pp.805-809, 2003. ,
ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression, Pharmacogenet. Genomics, vol.20, pp.467-475, 2010. ,
Description and classification of depressive disorders. Contributions for the definition of the therapy-resistance and of therapy resistant depressions, Pharmakopsychiatr. Neuropsychopharmakol, vol.7, pp.76-79, 1974. ,
Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression, Am. J. Psychiatry, vol.160, pp.522-532, 2003. ,
Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction, Br. J. Psychiatry, vol.200, pp.137-142, 2012. ,
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A, J. Clin. Invest, vol.96, pp.1698-1705, 1995. ,
Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress, Mol. Psychiatry, vol.15, pp.1152-1163, 2010. ,
Suppression of adult neurogenesis leads to an increased hypothalamo-pituitary-adrenal axis response, Neuroreport, vol.20, pp.553-557, 2009. ,
Identification of the cortical neurons that mediate antidepressant responses, Cell, vol.149, pp.1152-1163, 2012. ,
The prospect of FKBP51 as a drug target, Chem. Med. Chem, vol.7, pp.1351-1359, 2012. ,
Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety-and depression-like behavior, Neuropsychopharmacology, vol.38, pp.1234-1244, 2013. ,
The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression, PLoS ONE, vol.4, p.4324, 2009. ,
Depression as a risk factor for non-suicide mortality in the elderly, Biol. Psychiatry, vol.52, pp.205-225, 2002. ,
Effects of illness duration and treatment resistance on grey matter abnormalities in major depression, Br. J. Psychiatry, vol.202, pp.434-440, 2013. ,
Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity, Mol. Psychiatry, vol.6, pp.586-592, 2001. ,
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders, CNS Drugs, vol.22, pp.963-973, 2008. ,
Therapeutic options for treatment-resistant depression, CNS Drugs, vol.24, pp.131-161, 2010. ,
Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry, Pharmacogenomics, vol.11, pp.1305-1330, 2010. ,
Neurogenesis in the adult is involved in the formation of trace memories, Nature, vol.410, pp.372-376, 2001. ,
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression, Transl. Psychiatry, vol.2, p.198, 2012. ,
Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants, Psychiatr. Genet, vol.16, pp.153-158, 2006. ,
Adult hippocampal neurogenesis buffers stress responses and depressive behaviour, Nature, vol.476, pp.458-461, 2011. ,
Prolonged treatment of Cushing's disease with metyrapone and aminoglutethimide, IRCS Med. Sci, vol.14, pp.485-486, 1986. ,
Residual symptoms in depression. An emerging therapeutic concept, Prog. NeuroPsychopharmacol. Biol. Psychiatry, vol.26, pp.763-770, 2002. ,
Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease, Horm. Res, vol.39, pp.202-206, 1993. ,
Treatment resistant depression: methodological overview and operational criteria, Eur. Neuropsychopharmacol, vol.9, issue.98, pp.4-6, 1999. ,
Group for the study of resistant depression. clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study, J. Clin. Psychiatry, vol.68, pp.1062-1070, 2007. ,
Pharmacology of ionotropic glutamate receptors: a structural perspective, Bioorg. Med. Chem, vol.18, pp.7759-7772, 2010. ,
Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice, Pharmacogenomics J, vol.8, pp.196-208, 2008. ,
Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress, Behav. Brain Res, vol.206, pp.310-312, 2010. ,
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal, Biol. Psychiatry, vol.64, pp.293-301, 2008. ,
Antidepressants recruit new neurons to improve stress response regulation, Mol. Psychiatry, vol.16, pp.1177-1188, 2011. ,
CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype-phenotype association study design in translational pharmacogenetics, J. Psychopharmacol, vol.25, pp.908-914, 2011. ,
Alterations in 5-HT1B receptor function by p11 in depression-like states, Science, vol.311, pp.77-80, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-02185479
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder, Neurosci. Biobehav. Rev, vol.37, pp.911-929, 2013. ,
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression, Am. J. Med. Genet. B. Neuropsychiatr. Genet, vol.144, pp.325-331, 2007. ,
Hippocampal neurogenesis: a biomarker for depression or antidepressant effects. Methodological considerations and perspectives for future research, Cell Tissue Res, vol.354, pp.203-219, 2013. ,
Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants regionspecific, Neuroscience, vol.252, pp.234-252, 2013. ,
Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder, J. Am. Acad. Child Adolesc. Psychiatry, vol.48, pp.71-78, 2009. ,
, Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test, Eur. J. Pharmacol, vol.487, pp.133-142
Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients, Am. J. Pyschiatry, vol.163, pp.73-78, 2006. ,
Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials, J. Clin. Psychiatry, vol.72, pp.1660-1668, 2011. ,
When at first you don't succeed: sequential strategies for antidepressant nonresponders, J. Clin. Psychiatry, vol.58, pp.23-29, 1997. ,
Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders, Acta Psychiatr. Scand, vol.127, pp.355-364, 2013. ,
Homozygote mice deficient in serotonin 5-HT1B receptor and antidepressant effect of selective serotonin reuptake inhibitors, C. R. Seances Soc. Biol. Fil, vol.192, pp.1139-1147, 1998. ,
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice, Am. J. Psychiatry, vol.163, pp.28-40, 2006. ,
Adult-born neurons are necessary for extended contextual discrimination, Hippocampus, vol.22, pp.292-298, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02326414
Recruitment of adult-generated neurons into functional hippocampal networks contributes to updating and strengthening of spatial memory, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.5919-5924, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00365297
Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients, J. Affect. Disord, vol.113, pp.183-187, 2009. ,
Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment, Am. J. Med. Genet. B. Neuropsychiatr. Genet, vol.144, pp.1097-1098, 2007. ,
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone, J. Biol. Chem, vol.267, pp.24248-24252, 1992. ,
Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers, World J. Biol. Psychiatry, vol.10, issue.4, pp.832-835, 2009. ,
abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice, J. Psychiatr. Res, vol.37, pp.179-185, 2003. ,
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) Pglycoprotein gene disruption, Biol. Psychiatry, vol.54, issue.03, p.74, 2003. ,
Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins, 2002. ,
, J. Neuroendocrinol, vol.14, pp.753-759
Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption, Neuropsychopharmacology, vol.22, pp.380-387, 2000. ,
Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression, Neuron, vol.57, pp.203-209, 2008. ,
The topographical distribution of alpha-activity in the resting EEG of endogenous-depressive inpatients with and without clinical-response to pharmacotherapy, Pharmacopsychiatry, vol.19, pp.272-273, 1986. ,
, Frontiers in Pharmacology | Neuropharmacology, vol.4, 2013.
, , 2004.
Polymorphisms of the glucocorticoid receptor gene and major depression, Biol. Psychiatry, vol.59, pp.681-688, 2006. ,
Overview of antidepressant treatment of bipolar depression, Int. J. Neuropsychopharmacol, vol.22, pp.1-13, 2013. ,
Improving adherence to antidepressants: a systematic review of interventions, J. Clin. Psychiatry, vol.64, pp.1415-1420, 2003. ,
Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients, J. Psychopharmacol, vol.24, pp.497-502, 2010. ,
DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses, Nat. Neurosci, vol.13, pp.745-752, 2010. ,
Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein, Biol. Pharm. Bull, vol.31, pp.231-234, 2008. ,
Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells, J. Neuroscience, vol.28, pp.1374-1384, 2008. ,
A role for p11 in the antidepressant action of brainderived neurotrophic factor, Biol. Psychiatry, vol.68, pp.528-535, 2010. ,
Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation, J. Neurosci, vol.29, pp.1937-1946, 2009. ,
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans, Proc. Natl. Acad. Sci. U.S.A, vol.108, pp.9262-9267, 2011. ,
Inhibition of P-glycoprotein by newer antidepressants, J. Pharmacol. Exp. Ther, vol.305, pp.197-204, 2003. ,
Neurodevelopmental and neurophysiological actions of thyroid hormone, J. Neuroendocrinol, vol.20, pp.784-794, 2008. ,
Triiodothyronine alone and with imipramine in the treatment of depressed women, The Thyroid Axis, Drugs and Behavior, pp.49-61, 1974. ,
Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression, Transl. Psychiatry, vol.3, p.242, 2013. ,
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex, Am. J. Psychiatry, vol.156, pp.1149-1158, 1999. ,
Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response, J. Affect. Disord, vol.133, pp.165-173, 2011. ,
Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol, Eur. J. Pharmacol, vol.514, pp.165-174, 2005. ,
Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients, J. Clin. Psychopharmacol, vol.26, pp.367-372, 2006. ,
Loss of glucocorticoid fast feedback in depression, Arch. Gen. Psychiatry, vol.48, pp.693-699, 1991. ,
Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants, J. Neurosci, vol.32, pp.4092-4101, 2012. ,
Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response, Neuropsychopharmacology, vol.30, pp.1719-1723, 2005. ,
Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior, Neuropsychopharmacology, vol.34, pp.1067-1077, 2009. ,
p11 is up-regulated in the forebrain of stressed rats by glucocorticoid acting via two specific glucocorticoid response elements in the p11 promoter, Neuroscience, vol.153, pp.1126-1134, 2008. ,
Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach, Psychiatry Res, vol.139, pp.165-179, 2005. ,
, Conflict of Interest Statement: The authors declare that the research was con